Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference17 articles.
1. Inhibitors of MAO-A and MAO-B in psychiatry and neurology;Front Pharmacol,2016
2. Moclobemid in der Depressionsbehandlung—eine Übersicht;Psychiatr Prax,1989
3. Moclobemide, a substrate of CYP2C19 and an inhibitor of CYP2C19, CYP2D6, and CYP1A2: a panel study;Clin Pharmacol Ther,1995
4. Undesirable blood pressure changes under naturalistic treatment with moclobemide, a reversible MAO-A inhibitor—results of the drug utilization observation studies;Pharmacopsychiatry,1999
5. Antidepressant drug therapy: associated risks;J Neural Transm,1988